Type II innate lymphoid cell plasticity contributes to impaired reconstitution after allogeneic hematopoietic stem cell transplantation.
Saved in:
| Title: | Type II innate lymphoid cell plasticity contributes to impaired reconstitution after allogeneic hematopoietic stem cell transplantation. |
|---|---|
| Authors: | Laurie SJ; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA., Foster JP 2nd; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA.; Curriculum in Bioinformatics & Computational Biology, University of North Carolina, Chapel Hill, NC, USA., Bruce DW; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA., Bommiasamy H; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA., Kolupaev OV; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA.; Duke Eye Center, Duke University, Durham, NC, USA., Yazdimamaghani M; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA., Pattenden SG; Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA., Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Duke Cancer Institute, Durham, NC, USA., Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Duke Cancer Institute, Durham, NC, USA., Parker JS; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA.; Department of Genetics, University of North Carolina, Chapel Hill, NC, USA., Davis IJ; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA.; Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, USA., Serody JS; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA. jonathan_serody@med.unc.edu.; Department of Microbiology & Immunology, University of North Carolina School of Medicine, Chapel Hill, NC, USA. jonathan_serody@med.unc.edu.; Division of Hematology, University of North Carolina School of Medicine, Chapel Hill, NC, USA. jonathan_serody@med.unc.edu.; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA. jonathan_serody@med.unc.edu. |
| Source: | Nature communications [Nat Commun] 2024 Jul 17; Vol. 15 (1), pp. 6000. Date of Electronic Publication: 2024 Jul 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-024-50263-7 |
